Where Are They Now? Checking In With Four Alzheimer’s Disease Start-Ups
This article was originally published in Start Up
Executive Summary
Four start-ups previously profiled in START-UP – CoMentis, EnVivo Pharmaceuticals, Avid Radiopharmaceuticals and AC Immune SA – show how some biotechs have successfully ridden through the rough patches any company brave enough to tackle Alzheimer’s disease will likely face.